New York (AFP) March 15, 2021
American pharmaceutical companies Gilead and Merck announced Monday they have partnered to develop a new HIV therapy that could see daily medications replaced by a treatment that can be taken at longer intervals. The companies aim to combine two of their existing medications to “provide new, meaningful treatment options for people living with HIV,” the virus that causes AIDS, the companies s
http://dlvr.it/RvkLGv